171 related articles for article (PubMed ID: 15794248)
1. [Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].
Targowski T; Jahnz-Rózyk K; From S; Płusa T
Przegl Lek; 2004; 61(10):1049-51. PubMed ID: 15794248
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
Jahnz-Rózyk K; Targowski T; From S; Płusa T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
Targowski T; Jahnz-Rózyk K; From S; Płusa T
Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
[TBL] [Abstract][Full Text] [Related]
4. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
6. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
8. [Comparative analysis of nicotine dependence and motivation to quit smoking in patients with bronchial asthma or COPD].
Targowski T; Grabowska P; Rozyńska R; From S; Mierzejewska J; Niedziałkowski P
Przegl Lek; 2004; 61(10):1046-8. PubMed ID: 15794247
[TBL] [Abstract][Full Text] [Related]
9. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
10. Consequences of passive smoking in home environment.
Kałucka S
Przegl Lek; 2007; 64(10):632-41. PubMed ID: 18409274
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD).
Borglykke A; Pisinger C; Jørgensen T; Ibsen H
Clin Respir J; 2008 Jul; 2(3):158-65. PubMed ID: 20298324
[TBL] [Abstract][Full Text] [Related]
12. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
14. [Circulating adhesion molecules in patients with chronic obstructive pulmonary disease].
Yurdakul AS; Taci Hoca N; Cimen F; Balci M; Atikcan S
Tuberk Toraks; 2004; 52(4):356-62. PubMed ID: 15558358
[TBL] [Abstract][Full Text] [Related]
15. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
Slama K
Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
[TBL] [Abstract][Full Text] [Related]
16. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
17. Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments.
Rowe BH; Villa-Roel C; Guttman A; Ross S; Mackey D; Sivilotti ML; Worster A; Stiell IG; Willis V; Borgundvaag B
Acad Emerg Med; 2009 Apr; 16(4):316-24. PubMed ID: 19298621
[TBL] [Abstract][Full Text] [Related]
18. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.
Mittmann N; Kuramoto L; Seung SJ; Haddon JM; Bradley-Kennedy C; Fitzgerald JM
Respir Med; 2008 Mar; 102(3):413-21. PubMed ID: 18086519
[TBL] [Abstract][Full Text] [Related]
19. Excess healthcare cost associated with a low smoking prevalence, Barbados.
Lwegaba A
West Indian Med J; 2004 Jan; 53(1):12-6. PubMed ID: 15114887
[TBL] [Abstract][Full Text] [Related]
20. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
Drescher GS; Carnathan BJ; Imus S; Colice GL
Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
